2,8-Diacetylamino-1-tetralone → 8-Acetylamino-1-amino-6,7,8,9-tetrahydro-5H-benzocycloheptene-9-one
反応式
C([NH:4][C:5]1[C:10]2[C:11](=[O:20])[CH:12]([NH:16][C:17](=[O:19])[CH3:18])[CH2:13][CH2:14][CH2:15][C:9]=2[CH:8]=[CH:7][CH:6]=1)(=O)C.C(NC1CCC2C(=C(NC(=O)C)C=CC=2)C1=O)(=O)C>>[C:17]([NH:16][CH:12]1[C:11](=[O:20])[C:10]2[C:5]([NH2:4])=[CH:6][CH:7]=[CH:8][C:9]=2[CH2:15][CH2:14][CH2:13]1)(=[O:19])[CH3:18]参加物
3
実験手順
The reaction was carried out in the same manner as in Example 1-(4), except that 115 mg of the compound prepared in (3) above was used instead of 2,8-diacetylamino-1-tetralone of Example 1-(4). The product was post-treated to produce 90 mg of the title compound.
後処理
- additionThe product was post-treated
出典と根拠
- ORDレコード
- ord-1db09a5e0cad40ed9f47361e6597ad7c
- 出典データセット
- uspto-grants-1998_11
- 特許番号
- US05834476
反応ノート
読み込み中…